Ingrid Wertz
Chief Executive Officer Lyterian Therapeutics
Seminars
Wednesday 28th January 2026
Co-Opting the Ubiquitin System for Therapeutic Benefit
12:00 pm
- Reviewing rational drug design strategies for molecular glues
- Comparing and contrasting different molecular glue systems
- Investigating more streamlined and complementary strategies to evaluate optimized compounds
